Industry Reports

Novartis achieved strong financial results in 2010 -Net sales up 14% (+14% in constant currencies, or cc) to USD 50.6 billion. Solid sales growth in fourth quarter, operating income impacted by one-offs and A(H1N1) pandemic flu vaccine sales in...

Genzyme Corp. reported that preliminary fourth-quarter revenue grew 23 percent to $1.15 billion from $938 million in the fourth quarter of 2009. For the year, revenue was $4.1 billion compared with $4.0 billion in 2009. Fourth-quarter revenue from the...

The value of the global pharmaceutical market is expected to grow 5-7 percent in 2011, to US$880 billion, compared with a 4-5 percent pace this year, according to IMS Health. The forecast, included in the latest release of IMS...

BioMimetic Therapeutics, Inc. reported its financial results as of and for the three and nine months ended September 30, 2010.  For the three months ended September 30, 2010, the Company reported a net loss of $7.8 million, or $0.29...

GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the third quarter ended 30th September 2010. The Company has posted a Net Sales growth of 14% compared to the previous quarter, while Profit Before Tax and before Exceptional Items...

The Bayer Group significantly raised sales and underlying earnings in the third quarter of 2010. “We are pleased that our third-quarter results showed an improvement on last year, and we remain confident for the full year 2010,” Management Board...

ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, reported its financial results for the third quarter ended September 30, 2010.  Net revenues for the quarter were $225 million, representing a 2%...